Immunity I L nine signaling redirects C A R T cell fate toward C D eight positive memory and C D four positive cycling states, enhancing antitumor efficacy
Immunity I L nine signaling redirects C A R T cell fate toward C D eight positive memory and C D four positive cycling states, enhancing antitumor efficacy
In brief
Castelli et al. show that incorporating interleukin-nine I L nine signaling reprograms chimeric antigen receptor C A R T cells to expand, persist, and resist dysfunction in solid tumors. This strategy improves antitumor activity at lower doses, suggesting a promising way to enhance the effectiveness of C A R T cell therapies against solid cancers.
Highlights
Highlights
. Engineering C A R T cells with I L nine signaling boosts efficacy against solid tumors
. I L nine-signaling C D four positive C A R T cells have increased T H one and proliferative phenotypes
. Single-cell profiling reveals that I L nine redirects C D eight positive T cell fate away from dysfunction
. I L nine-induced S T A T one/S T A T four activation contributes to improved C A R T cell function